BACK

Mark Simon

Partner and Co-Founder

New York Office  |  mark.simon@torreya.com   |   212.257.5809

Mark Simon, Torreya Partner and Co-Founder, heads the Biotech Advisory Team and participates in many of the firm’s biotech, pipeline, and specialty pharma transactions. He has expansive scientific and clinical knowledge across multiple therapeutic areas. In 30 plus years of advising biotech and specialty pharma companies, he has worked on more than 175 financing and M&A transactions totaling over $50 billion in value.

Before co-founding Torreya in 2007, Mark was a Managing Director and the Head of Life Sciences Investment Banking at Citigroup, where he covered global pharmaceutical companies, with a focus on large-capitalization players in the US, Europe, and Japan. Prior to his tenure at Citigroup, Mark served as a Managing Director at Robertson Stephens in San Francisco and New York. There, he was involved in raising 45% of all biotech dollars raised in the US from 1999-2001.

Before moving into investment banking, Mark was a Senior Biotech Research Analyst at Robertson Stephens, where he was named Wall Street All-Star Analyst three years in a row. He began his career as a Research Associate at Kidder Peabody in New York in 1984, covering biotechnology and health care services companies.

Mark holds a B.A. in history from Columbia College and an M.B.A. from Harvard Business School.

He is Senior Advisor to the Milken Family Foundation’s Prostate Cancer Foundation and a Director of the Alliance for Aging Research.